Watch Ticker

Akero Therapeutics, Inc. Common Stock

Go to Akero Therapeutics, Inc. Common Stock Website

$49.56

0.00 (0.00%)

Live

Previous Close

$49.56

Day Range

$0 - $0

Previous Day Range

$48.073 - $49.815

Market Cap

$3.9 billion USD

Day Vol.

Previous Day Vol.

1.0 million

Currency

USD

Primary Exchange

Nasdaq

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NA...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Akero Therapeutics und HistoIndex präsentieren neue Analysen der Phase-IIb-Studie HARMONY in Vorträgen und Postern auf dem EASL-Kongress 2025

Akero Therapeutics and HistoIndex presented new analyses from the Phase IIb HARMONY study at the EASL 2025 Congress, highlighting the potential of AI-based digital pathology in assessing histopathological response to Efruxifermin (EFX) in patients with pre-cirrhotic MASH.

Related tickers: AKRO.

Read Full Article

N/A - Akero Therapeutics et HistoIndex présentent de nouvelles analyses de l’essai de phase IIb HARMONY lors de présentations orales et d’affiches lors du congrès 2025 de l’EASL

Akero Therapeutics and HistoIndex presented new analyses from the Phase 2b HARMONY trial at the 2025 EASL congress, highlighting the potential of AI-based digital pathology to assess histopathological response to Akero's drug candidate efruxifermine in patients with pre-cirrhotic NASH.

Related tickers: AKRO.

Read Full Article

Trending Tickers

Please sign in to view